Literature DB >> 14695677

Antigenic and genetic characterization of serotype G2 human rotavirus strains from South Africa from 1984 to 1998.

N A Page1, A D Steele.   

Abstract

Within South Africa, cyclic peaks of serotype G2P[4] rotavirus infection have been observed and these strains were prevalent in some locations. To examine the cyclic phenomenon of serotype G2 rotaviruses, historical stool collections from South Africa spanning 15 years were screened for G2 strains. Subgroup (VP6) ELISA, polyacrylamide gel electrophoresis (PAGE), and P genotyping were performed on 43 G2 strains to investigate the associated DS-1 genogroup characteristics. Antigenic variation of the gene encoding the major neutralization glycoprotein (VP7) was also investigated using G2-specific monoclonal antibodies. In addition, the VP7 gene of 14 serotype G2 strains was sequenced to examine genetic variation. Serotype G2 strains from South Africa displayed a 10 year cyclic pattern with major epidemics occurring in 1987 and 1997. Serotype G2 strains were also found co-dominant with G(1) strains in 1984, 1990, and 1993. The G2 strains from the major epidemics appeared to have emerged from community strains in a manner similar to that suggested for G(1) strains The serotype G2 strains displayed subgroup I specificity and short electropherotypes characteristic of DS-1 genogroup rotavirus strains but appeared to differ in the VP4 gene. Genetic analyses revealed three major serotype G2 lineages, i.e., strains isolated prior to 1987, strains isolated between 1988 and 1994, and strains isolated from 1995. The use of monoclonal antibodies and PCR primers designed against older G2 strains has resulted in the failure to serotype G2 strains circulating currently. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695677     DOI: 10.1002/jmv.10571

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Antigenic and genetic characterization of serotype G2 human rotavirus strains from the African continent.

Authors:  N A Page; A D Steele
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions.

Authors:  Virginia E Pitzer; Manish M Patel; Ben A Lopman; Cécile Viboud; Umesh D Parashar; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

3.  Detection of Common, Emerging and Uncommon VP4, and VP7 Human Group A Rotavirus Genotypes from Urban Sewage Samples in Uruguay.

Authors:  Luis Fernando Lopez Tort; Matías Victoria; Andrés Lizasoain; Mariana García; Mabel Berois; Juan Cristina; José Paulo Gagliardi Leite; Mariela Martínez Gómez; Marize Pereira Miagostovich; Rodney Colina
Journal:  Food Environ Virol       Date:  2015-08-13       Impact factor: 2.778

4.  Development of a microtiter plate hybridization-based PCR-enzyme-linked immunosorbent assay for identification of clinically relevant human group A rotavirus G and P genotypes.

Authors:  Norma Santos; Shinjiro Honma; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

5.  Effect of monovalent rotavirus vaccine on rotavirus disease burden and circulating rotavirus strains among children in Morocco.

Authors:  Mohammed Benhafid; Nezha Elomari; Meryem Azzouzi Idrissi; Ahmed Rguig; Jon R Gentsch; Umesh Parashar; Rajae Elaouad
Journal:  J Med Virol       Date:  2015-03-05       Impact factor: 2.327

6.  Rotavirus genetic diversity, disease association, and temporal change in hospitalized rural Kenyan children.

Authors:  D James Nokes; Ina Peenze; Lufuno Netshifhefhe; John Abwao; Mariet C De Beer; Mapaseka Seheri; Thomas N Williams; Nicola Page; Duncan Steele
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

7.  Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014.

Authors:  N A Page; L M Seheri; M J Groome; J Moyes; S Walaza; J Mphahlele; K Kahn; C N Kapongo; H J Zar; S Tempia; C Cohen; S A Madhi
Journal:  Vaccine       Date:  2017-10-27       Impact factor: 3.641

8.  Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.

Authors:  Andrew Duncan Steele; Kathleen M Neuzil; Nigel A Cunliffe; Shabir A Madhi; Pieter Bos; Bagrey Ngwira; Desiree Witte; Stacy Todd; Cheryl Louw; Mari Kirsten; Sanet Aspinall; Leen Jan Van Doorn; Alain Bouckenooghe; Pemmaraju V Suryakiran; Htay Htay Han
Journal:  BMC Infect Dis       Date:  2012-09-13       Impact factor: 3.090

9.  Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.

Authors:  Sheila Isanaka; Céline Langendorf; Monica Malone McNeal; Nicole Meyer; Brian Plikaytis; Souna Garba; Nathan Sayinzoga-Makombe; Issaka Soumana; Ousmane Guindo; Rockyiath Makarimi; Marie Francoise Scherrer; Eric Adehossi; Iza Ciglenecki; Rebecca F Grais
Journal:  PLoS Med       Date:  2021-07-02       Impact factor: 11.069

10.  Rotavirus Genotypes in Hospitalized Children With Acute Gastroenteritis Before and After Rotavirus Vaccine Introduction in Blantyre, Malawi, 1997-2019.

Authors:  Chimwemwe Mhango; Jonathan J Mandolo; End Chinyama; Richard Wachepa; Oscar Kanjerwa; Chikondi Malamba-Banda; Prisca B Matambo; Kayla G Barnes; Chrispin Chaguza; Isaac T Shawa; Martin M Nyaga; Daniel Hungerford; Umesh D Parashar; Virginia E Pitzer; Arox W Kamng'ona; Miren Iturriza-Gomara; Nigel A Cunliffe; Khuzwayo C Jere
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.